Lyrica (pregabalin) and baclofen are both used to calm overactive nerve signaling, but they work through entirely different molecular targets and carry distinct risk profiles when taken together. Pregabalin binds to calcium channel subunits in the nervous system, while baclofen activates GABA-B receptors. Because both drugs independently depress the central nervous system, their combination can produce unexpectedly deep sedation, and at least one published case report documents a patient falling into a coma on doses that would be considered routine for either drug alone. Understanding how these two medications overlap and diverge matters whether you take both, are considering a switch, or simply want to know why your prescriber treats them so differently.
How Each Drug Works
Pregabalin, sold as Lyrica, binds to a protein called the alpha-2-delta-1 subunit on voltage-gated calcium channels. When pregabalin locks onto this subunit, less calcium flows into nerve terminals, which reduces the release of excitatory neurotransmitters and dials down pain signaling.1PubMed Central. Calcium Channel α(2)δ Ligands Mirogabalin, Pregabalin, and Gabapentin: Advancements in Diabetic Peripheral Neuropathic Pain Therapeutics Transgenic mouse studies have confirmed that this subunit is essentially the sole molecular target responsible for pregabalin’s pain-relieving effect; when the subunit is knocked out or mutated, the drug stops working entirely.2PubMed Central. Mechanisms of the gabapentinoids and α 2 δ ‐1 calcium channel subunit in neuropathic pain This mechanism is why pregabalin is classified as a gabapentinoid alongside gabapentin, even though neither drug actually acts on GABA receptors despite the confusing name.
Baclofen takes a completely different route. It is a selective agonist of GABA-B receptors, meaning it mimics the inhibitory neurotransmitter GABA at one of its two main receptor types. On the postsynaptic side, baclofen opens potassium channels, which makes the neuron less likely to fire. On the presynaptic side, it reduces neurotransmitter release.3Progress in Neurobiology. A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system Research on peripheral nerve endings has shown that baclofen’s pain-relieving action in the periphery also depends on activating potassium channels, specifically the type blocked by tetraethylammonium.4PubMed Central. Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels
The practical takeaway from these different mechanisms is that pregabalin and baclofen are not redundant. They suppress nerve activity through different molecular doorways, which is exactly why doctors sometimes prescribe them together for conditions like post-surgical pain or spasticity with neuropathic overlay. It is also why the combination can be more dangerous than you might expect from either drug’s safety profile alone.
The Danger of Taking Them Together
Neither pregabalin nor baclofen is metabolized by the liver’s cytochrome P450 enzyme system, so on paper they should not produce a conventional drug-drug interaction. Both are cleared primarily by the kidneys. But the clinical reality is less reassuring. A published case report describes a 68-year-old woman who developed progressive drowsiness and then coma after receiving baclofen at 30 mg per day alongside pregabalin at 300 mg per day following spinal fusion surgery. Her kidney function was only mildly reduced. The CNS depression fully resolved within 48 hours of stopping both drugs.5PubMed Central. Case Report: Synergistic central nervous system depression of baclofen and pregabalin: clinical pharmacist-driven case analysis and case review The authors described the interaction as synergistic rather than merely additive, meaning the combined effect was greater than what you would predict by adding each drug’s sedation together.
What makes this case striking is that neither dose was unusual. Baclofen at 30 mg per day and pregabalin at 300 mg per day are both well within standard prescribing ranges. The patient’s kidney impairment was mild enough that many clinicians would not have flagged it. Yet together, these routine doses produced a coma. If you are prescribed both medications, even modest reductions in kidney function could tip the balance toward toxicity, and the warning signs, such as increasing sleepiness, confusion, and difficulty staying awake, should prompt urgent contact with your prescriber.
Why Kidney Function Matters for Both Drugs
Since both pregabalin and baclofen exit the body through the kidneys with minimal liver processing, anything that slows kidney filtration raises drug levels in the blood. For baclofen, the consequences of impaired clearance can be severe. A review in the American Journal of Kidney Diseases recommended reducing baclofen doses when kidney filtration is moderately reduced and avoiding the drug entirely when filtration drops below roughly 30 mL/min or in people on dialysis.6PubMed. Baclofen Toxicity in Kidney Disease Case reports of baclofen toxicity in dialysis-dependent patients describe severe neurological symptoms that required continuous hemodialysis sessions before the patient recovered.7PubMed Central. Baclofen Toxicity in a Dialysis-Dependent Patient: A Case Report
Pregabalin faces a similar constraint. Its prescribing information calls for dose reductions as kidney function declines, and failure to adjust for renal impairment is a recurring theme in adverse event reports. When both drugs are prescribed together and kidney function is anything less than robust, the accumulation problem compounds because both agents build up simultaneously. The synergistic CNS depression case described above occurred in a patient whose kidney function was only mildly impaired, which underscores that even a small decline in filtration can matter when two renally cleared sedating drugs overlap.
A pediatric case report of baclofen overdose in a child with normal kidney function found that the kidneys cleared baclofen effectively on their own and that hemodialysis removed a negligible additional amount.8PubMed. Removal of baclofen with hemodialysis is negligible compared to intact kidney excretion in a pediatric overdose In other words, healthy kidneys handle baclofen well, but once they falter, there is no easy backup mechanism.
How They Compare for Neuropathic Pain
People sometimes wonder whether one of these drugs could replace the other. In a rodent model of neuropathic pain using chronic nerve constriction, both pregabalin and baclofen reduced thermal and mechanical pain responses, but pregabalin outperformed baclofen at every time point measured over a two-hour period.9International Journal of Basic & Clinical Pharmacology. Comparative efficacy of pregabalin and baclofen in the rodent chronic constriction injury model of neuropathic pain This aligns with clinical experience: pregabalin has regulatory approval for neuropathic pain conditions such as diabetic neuropathy and post-herpetic neuralgia, whereas baclofen does not. Baclofen’s primary approved indication is spasticity from conditions like multiple sclerosis and spinal cord injury.
That said, baclofen does provide meaningful pain relief in some patients, especially where spasticity and pain coexist. Muscle spasms themselves can be intensely painful, and treating the spasm with baclofen may indirectly reduce pain. So while pregabalin is the stronger standalone analgesic for nerve pain, baclofen is not useless for pain; it just works best when spasticity is part of the picture. This is one reason the two drugs end up prescribed together after spinal surgeries or in neurological conditions where both spasticity and neuropathic pain are present.
Withdrawal Risks
Both drugs carry withdrawal risks if stopped abruptly, though the nature and severity differ. Baclofen withdrawal can be genuinely dangerous. A published case describes a 62-year-old woman whose oral baclofen was inadvertently not continued at a skilled nursing facility after surgery. She developed altered mental status and respiratory insufficiency severe enough to require intensive care admission.10PubMed Central. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission Baclofen withdrawal can mimic or progress to symptoms resembling those of alcohol or benzodiazepine withdrawal, including seizures and delirium, because all three involve GABA-mediated inhibition being suddenly removed.
Pregabalin withdrawal tends to be less acutely dangerous but is still unpleasant, with symptoms including insomnia, anxiety, sweating, nausea, and sometimes rebound pain. Prescribing guidelines typically recommend tapering pregabalin over at least a week rather than stopping cold. If you are on both drugs and a change is planned, your doctor will usually taper one at a time to avoid overlapping withdrawal effects.
One scenario that catches people off guard is hospitalization. If you are admitted for surgery or another reason and your home medications are not accurately recorded, either drug could be abruptly discontinued. Carrying an up-to-date medication list can prevent this.
Misuse and Abuse Potential
Pregabalin has drawn considerably more regulatory attention for misuse than baclofen has. In the United States, pregabalin is a Schedule V controlled substance, the lowest tier of scheduling. In the United Kingdom, it has been classified as a Class C controlled drug. A systematic review found that pregabalin appeared somewhat more addictive than its cousin gabapentin, with more behavioral dependence symptoms and more transitions from prescribed use to self-administration at escalating doses.11PubMed. How addictive are gabapentin and pregabalin? A systematic review Clinical studies have reported euphoria as a frequent side effect, and the majority of case reports involving pregabalin abuse have occurred in people with a prior history of substance use, especially opioid misuse.12PubMed. Abuse Potential of Pregabalin: A Systematic Review
The people most at risk for misusing pregabalin tend to be those who use multiple recreational drugs and who self-administer at doses far exceeding clinical recommendations, sometimes 3 to 20 times the prescribed amount.13PubMed. Misuse and abuse of pregabalin and gabapentin: cause for concern? At standard therapeutic doses, the addictive potential appears low for people without a substance use history. Still, if you have a history of addiction, your prescriber should know before starting Lyrica.
Baclofen presents a different misuse profile. Rather than being sought for euphoria, baclofen is more commonly associated with accidental toxicity through dose escalation, particularly in people using it off-label for alcohol cravings at doses that climb well above the standard range for spasticity.
Baclofen for Alcohol Use Disorder
An entirely separate clinical conversation around baclofen has emerged over the past two decades: its use in treating alcohol dependence. Because GABA-B receptor activation can blunt alcohol craving and reduce the rewarding properties of drinking, baclofen has been tested in numerous trials for alcohol use disorder. A review identified 15 randomized controlled trials, most using fixed doses of 30 to 80 mg per day, though some clinicians have titrated patients to maintenance doses exceeding 300 mg per day to achieve the desired effect.14PubMed Central. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
A dose-response meta-analysis found that increasing baclofen up to about 50 to 60 mg per day was associated with more days of abstinence and reduced craving. Above 60 mg per day, the evidence became too thin and heterogeneous to draw reliable conclusions, and higher doses increased the risk of people dropping out of trials due to side effects.15PubMed. Optimal Dose of Baclofen for the Treatment of Alcohol Use Disorder: A Systematic Review and Dose-Response Meta-analysis A Cochrane review found that dropout rates were actually lower among participants receiving higher doses in studies lasting longer than 12 weeks, suggesting that people who tolerate the drug long enough to stabilize may stick with treatment more reliably.16PubMed Central. Baclofen for alcohol use disorder
This use of baclofen is relevant to the Lyrica question because people being treated for alcohol dependence with baclofen may also have neuropathic pain from alcohol-related nerve damage, and pregabalin is a common treatment for that kind of pain. Prescribers face a tension here: the patient needs both, but combining the two drugs raises the CNS depression risk discussed earlier, and the patient population may already carry vulnerability to respiratory depression.
The Opioid Overlap Problem
The risk picture gets more serious when opioids enter the equation. Many people prescribed baclofen for spasticity or pregabalin for neuropathic pain are also on opioid painkillers. Research in mice found that even a low dose of pregabalin that did not itself depress breathing could reverse tolerance to morphine’s respiratory depression, producing significant breathing suppression that would not have occurred with either drug alone. At higher doses, pregabalin’s own respiratory effects added to morphine’s. Deaths involving gabapentinoids (pregabalin and gabapentin) rose sharply in the UK, reaching 137 in 2015, with roughly four out of five of those deaths also involving opioids.17PubMed Central. Risk to heroin users of polydrug use of pregabalin or gabapentin
If you add baclofen’s own sedating and respiratory-depressant properties to a pregabalin-opioid combination, the risk multiplies further. This triple combination, while not uncommon in pain management after major surgery or in chronic pain clinics, demands careful dose management and close monitoring. If you are on all three categories of medication, even temporary kidney function changes from dehydration or illness could shift you from a safe therapeutic window into dangerous territory.
Pregnancy and Neonatal Considerations
Pregnant women with spinal cord injuries often need to continue baclofen to manage spasticity, but what happens to the baby at birth is not well understood. A case report describes a male infant born at about 34 weeks whose mother had taken baclofen 30 mg four times daily throughout pregnancy. Within 15 minutes of birth, the infant had an episode of extensor posturing that raised concern for withdrawal. He was started on a baclofen taper within hours of birth, monitored with a neonatal abstinence scoring tool, and successfully weaned off by day 14 with no apparent neurological deficits.18PubMed. Neonatal baclofen withdrawal following intrauterine exposure
Pregabalin carries its own pregnancy concerns. Animal studies have shown developmental toxicity at high doses, and it is generally considered a drug to avoid in pregnancy unless the benefit clearly outweighs the risk. For women who rely on both medications, conversations about family planning should happen well before conception, because both drugs need to be tapered slowly rather than stopped suddenly, and alternative treatments for spasticity and pain during pregnancy are limited.
Practical Guidance for People on Both Drugs
If your doctor prescribes Lyrica and baclofen together, a few practical points are worth knowing. First, get your kidney function checked before starting and periodically afterward, because even mild decline changes how both drugs accumulate. Second, pay attention to drowsiness that worsens over the first week or two; increasing sleepiness is the earliest sign that blood levels are climbing too high. Third, never stop either drug abruptly. Baclofen withdrawal can produce a medical emergency, and pregabalin withdrawal, while less dangerous, can flare the pain or anxiety you were treating. Any dose changes should be gradual and managed by your prescriber.
Alcohol deserves particular caution. Both drugs amplify alcohol’s sedating effects, and if you are taking baclofen specifically for alcohol cravings, mixing in pregabalin without your treatment team’s knowledge can push you toward the kind of CNS depression documented in the case literature. Be transparent with every provider involved in your care about the full list of medications you take, including over-the-counter sleep aids and supplements that have sedating properties.
Finally, keep in mind that these drugs are not interchangeable. Switching from one to the other is not a matter of swapping pills. They treat overlapping but distinct symptom profiles through entirely different mechanisms, and a patient who responds to baclofen for spasticity may not get the same benefit from pregabalin, and vice versa for neuropathic pain. The decision to use one, the other, or both should reflect the specific conditions being treated, your kidney health, and what else you are taking.